A semaglutide consultation should determine whether the medication is appropriate before treatment begins. A qualified provider should review the patient’s medical history, metabolic health, contraindications, and treatment goals before prescribing semaglutide. Consultation and prescribing requirements vary by state, so clinics should confirm the physician oversight rules that apply to their practice.
Key Takeaways
- A semaglutide consultation includes a live evaluation with a qualified provider before treatment is prescribed. (Jump to Section)
- Contraindication screening helps identify patients who should not receive semaglutide or require additional evaluation. (Jump to Section)
- Follow-up visits help monitor dosing, side effects, and treatment progress throughout therapy. (Jump to Section)
- Semaglutide prescribing should comply with state-specific physician oversight and delegation requirements. (Jump to Section)
What a Real Semaglutide Consultation Looks Like
A semaglutide consultation should establish whether treatment is medically appropriate before the first prescription is issued. The evaluation also helps identify health conditions, contraindications, and treatment goals that influence the prescribing decision.
Below is how a complete consultation typically includes the following:
Medical History Review
The provider reviews current medical conditions, previous weight management efforts, medications, allergies, and other factors that could affect treatment safety or prescribing decisions. This step often includes screening for conditions like thyroid disorders, pancreatitis history, or gallbladder disease, since these can influence whether semaglutide is appropriate. A thorough review also helps the medical director overseeing the clinic confirm that documentation supports the prescribing decision if it’s ever audited.
Weight and Metabolic Assessment
Weight history, body mass index, metabolic conditions, and related health concerns help determine whether semaglutide is an appropriate treatment option and establish a baseline for future follow-up. Providers typically also review markers such as blood pressure, glucose levels, or lipid panels when available, since these can shape dosing decisions and monitoring frequency. Establishing this baseline early makes it easier to track meaningful progress and catch any red flags as treatment continues.
Treatment Goals
The consultation should include a discussion about the patient’s weight loss goals, expectations, lifestyle habits, and long-term treatment plan. This conversation helps establish realistic clinical objectives before therapy begins. It should also cover how progress will be measured over time, including follow-up care and treatment plan documentation, so both the patient and provider have a shared understanding of what success looks like.
Live Provider Evaluation
The consultation should take place through an in-person visit or a live telehealth encounter with a qualified provider when permitted by state law. A questionnaire alone does not replace a clinical evaluation required to establish the patient-provider relationship. Clinics offering GLP-1 treatment remotely should confirm their telehealth compliance requirements are met, since rules on live evaluation vary by state and can affect prescribing authority. Working with a collaborating physician who understands these state-specific nuances helps ensure the evaluation itself holds up to regulatory scrutiny.
Support Compliant Semaglutide Prescribing
Qualified physician placement with attorney-reviewed agreements.
Contraindication Screening
Contraindication screening helps determine whether semaglutide can be prescribed safely. Before treatment begins, the provider should review medical conditions and risk factors that could make the medication inappropriate or require additional evaluation.
A semaglutide consultation should screen for:
Personal or Family History of Certain Thyroid Cancers
Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not receive semaglutide. The provider should review this history before prescribing treatment. This screening step is non-negotiable, and clinics should have a clear protocol for documenting the conversation as part of their weight loss clinic intake process.
History of Pancreatitis
Patients with a history of pancreatitis require careful clinical evaluation before starting semaglutide. The provider should determine whether treatment is appropriate based on the patient’s medical history and current health status. This is one of the reasons ongoing clinical oversight matters throughout a GLP-1 program, not just at intake, since a provider familiar with the patient’s full history is better positioned to catch warning signs early.
Pregnancy Status
Semaglutide is not recommended during pregnancy. The consultation should confirm pregnancy status and discuss appropriate treatment options before prescribing the medication. Providers should also address contraception planning during this conversation, since treatment may need to pause if a patient becomes pregnant while on therapy.
Additional Medical Conditions
The provider should also review gastrointestinal disorders, gallbladder disease, kidney disease, and other medical conditions that could affect treatment safety or ongoing monitoring. Clinics treating patients with overlapping conditions often benefit from coordinated input, such as nutrition counseling, to support safer, more sustainable outcomes alongside medication.
Documenting these findings helps support safe prescribing and provides a clinical basis for the treatment decision.
Follow-Up Is Part of Semaglutide Treatment
Follow-up visits help confirm that semaglutide remains appropriate as treatment progresses. Providers monitor dosing, treatment response, side effects, and changes in the patient’s health before continuing or adjusting therapy. Consistent follow-up also protects the clinic, since it creates a documented record that supports the medical director’s oversight responsibilities over time.
Follow-up appointments commonly include:
Dose Adjustments
Semaglutide dosing is typically increased over time. The provider should evaluate the patient’s response before adjusting the dose according to the treatment plan. This gradual titration is designed to reduce side effects while still moving the patient toward their treatment goals.
Side Effect Monitoring
Patients should be assessed for nausea, vomiting, gastrointestinal symptoms, and other adverse effects that could affect treatment or require clinical intervention. Catching these symptoms early often means the difference between a simple dose adjustment and discontinuing treatment altogether.
Progress Evaluation
Weight loss, treatment response, lifestyle changes, and adherence should be reviewed throughout therapy. Regular follow-up helps determine whether treatment goals are being achieved safely. Clinics offering care through telehealth should ensure these check-ins are just as thorough as in-person visits, since consistent monitoring is what keeps remote programs compliant and effective.
Ongoing Clinical Assessment
Changes in medications, medical conditions, or overall health should be reviewed during follow-up visits. New clinical findings can affect whether semaglutide remains appropriate for the patient, which is why many clinics rely on a collaborating physician to help reassess the treatment plan as the patient’s health picture evolves.
The timing of follow-up visits depends on the patient’s clinical needs and applicable state requirements. Clinics should establish follow-up protocols that support safe prescribing and ongoing patient monitoring.
How Medical Director Co. Supports Compliant Semaglutide Consultations
Medical Director Co. matches weight loss clinics and med spas with qualified physicians who understand state-specific semaglutide prescribing, good faith exam, and delegation requirements. Every placement includes:
- Qualified physician matching: Get matched with a physician licensed in your state and experienced in GLP-1 and weight loss programs.
- Attorney-reviewed agreements: Receive physician oversight agreements prepared to support state-specific compliance requirements.
- 24-hour placement: Most clinics are matched with a qualified physician within one business day.
- Ongoing compliance support: Receive continued guidance as your clinic grows and state requirements change.
Medical Director Co. helps clinics establish compliant physician oversight before semaglutide treatment begins.
Support Compliant Semaglutide Prescribing
Qualified physician placement with attorney-reviewed agreements.
Frequently Asked Questions
Is an online questionnaire enough for a semaglutide prescription?
A questionnaire alone does not establish the patient-provider relationship required for prescribing semaglutide. The patient should complete a live evaluation with a qualified provider through an in-person visit or telehealth encounter when permitted by state law.
What contraindications should a semaglutide consultation screen for?
The consultation should review a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), pancreatitis history, pregnancy status, and other medical conditions that could affect treatment safety or prescribing decisions.
Does the consultation need to happen live?
A semaglutide consultation should be completed through an in-person visit or a live telehealth encounter with a qualified provider when permitted by state law. Completing an online form alone does not replace a clinical evaluation.
How often should follow-up visits happen?
Follow-up visits should occur throughout treatment to monitor dosing, side effects, and patient progress. The frequency depends on the patient’s clinical needs, treatment plan, and applicable state requirements.
Who can conduct a semaglutide consultation?
A physician, nurse practitioner, or physician assistant with appropriate prescriptive authority can conduct the consultation. State law determines the supervision, collaboration, or delegation requirements that apply before semaglutide is prescribed.
Every Semaglutide Prescription Should Start with a Proper Evaluation
A semaglutide consultation establishes whether treatment is appropriate before the first prescription is issued. The evaluation should include a review of the patient’s medical history, contraindications, treatment goals, and ongoing monitoring needs. Clinics should follow applicable state requirements to support safe prescribing and compliant patient care.
Establish a Compliant Semaglutide Program
Qualified physician placement with attorney-reviewed agreements.
Bolton M. Harris, J.D., is a seasoned attorney with a formidable background in criminal law and a focus on healthcare law and compliance. As the in-house legal counsel at Medical Director Co., Harris brings a unique blend of prosecutorial experience and regulatory expertise to support healthcare professionals across Texas. Her career spans roles as a prosecutor in multiple counties and now as a trusted advisor on the legal intricacies of medical practice operations.
Education & Early Career
Bolton Harris completed her undergraduate studies at Southern Methodist University (SMU) in 2013. During her time at SMU, she was not only a dedicated student but also a competitive athlete on the university’s women’s swimming team. She went on to earn her Juris Doctor from Texas A&M University School of Law in 2016 and became a member of the Texas Bar that same year. Armed with a strong academic foundation and discipline honed as a student-athlete, Harris embarked on a career in criminal law immediately after law school.
Prosecutorial Experience in Texas
Bolton Harris began her legal career in public service as a criminal prosecutor. She served as an Assistant District Attorney in multiple jurisdictions, where she quickly rose through the ranks and handled a broad spectrum of cases. Some highlights of her prosecutorial career include:
- Assistant District Attorney, Dallas County, Texas: Prosecuted a high volume of criminal cases in one of the state’s busiest DA offices, gaining extensive trial experience in both misdemeanor and felony courts.
- Assistant District Attorney, Ellis County, Texas: Continued to hone her courtroom advocacy skills, known for meticulous case preparation and a tenacious pursuit of justice on behalf of the community.
- Assistant District Attorney, Navarro County, Texas: Broadened her legal expertise by handling diverse criminal matters in a smaller county, working closely with law enforcement and community leaders to uphold the law.
Through these roles, Harris built a reputation for being a tough but fair advocate. She brought numerous cases to trial and developed an in-depth understanding of the criminal justice system. This distinguished prosecutorial background laid a strong foundation for the next phase of her career in the private sector.
Healthcare Law & Compliance at Medical Director Co.
After her tenure as a prosecutor, Harris shifted her focus to healthcare law, applying her legal acumen to the medical field. She recognized that the same attention to detail and tenacity that served her in criminal law could benefit healthcare providers navigating complex regulations. Embracing this new direction, Harris became well-versed in the intricate laws governing medical practices – from licensing requirements to patient safety and privacy standards – and is passionate about helping practitioners stay compliant.
In her current role as the in-house attorney for Medical Director Co., Bolton Harris oversees all legal and compliance matters for the organization and its clients. Medical Director Co. is a nurse-owned firm that connects nurse practitioners (NPs), physician assistants (PAs), and registered nurses with qualified medical directors and collaborating physicians, offering fast placements and comprehensive compliance support for healthcare practices. Harris ensures that each of these partnerships and clinical ventures adheres to all applicable state and federal laws. She is responsible for drafting and reviewing collaborative practice agreements, advising on regulatory requirements, and providing ongoing legal counsel as clients establish and grow their clinics. Drawing on her prosecutorial eye for risk management, Harris proactively identifies potential legal issues and addresses them before they escalate, giving healthcare professionals peace of mind.
Bolton M. Harris’s multifaceted expertise – spanning high-stakes courtroom litigation to detailed healthcare compliance – makes her a formidable legal ally. Whether advocating in front of a jury or guiding a medical practice through regulatory hurdles, she remains committed to the highest standards of the legal profession. Her blend of courtroom-tested skill and healthcare law knowledge ensures that clients of Medical Director Co. receive elite-level counsel and steadfast protection in an ever-evolving legal landscape.
